Plasmablastic Lymphoma
📧 Sign up to get email alerts when something new happens for Plasmablastic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma [Phase 1]
A Phase 1 study evaluating Teclistamab in patients with recurrent or refractory plasmablastic lymphoma; the trial status is NOT_YET_RECRUITI…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease [Phase 2]
A National Cancer Institute-supported Phase 2 trial evaluating daratumumab in relapsed/refractory primary effusion lymphoma, plasmablastic l…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma [Phase 2]
A Phase 2 trial of belantamab mafodotin in relapsed/refractory plasmablastic lymphoma and ALK-positive large B-cell lymphoma was terminated,…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas [Phase 1]
Phase 1 trial evaluating pomalidomide with dose-adjusted EPOCH, with or without rituximab, for HIV-associated lymphomas; recruitment is ongo…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients. [Phase 2]
Phase 2 clinical trial evaluating a combination of daratumumab, bortezomib, and dexamethasone in patients with plasmablastic lymphoma. The s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Study on Plasmablastic Lymphoma Patients
A clinical trial update indicates a study on plasmablastic lymphoma sponsored by Fondazione Italiana Linfomi is currently recruiting. No res…
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies [Phase 1]
A Phase 1 clinical trial update for RN1201 injection in relapsed/refractory CD19+/BCMA+ hematologic malignancies, currently not recruiting.
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
AIDS Malignancy Consortium is recruiting for a study to collect blood and tissue samples from participants with HIV/AIDS-related cancers to …
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma [EARLY_Phase 1]
This early-phase study tests daratumumab with dose-adjusted EPOCH for plasmablastic lymphoma and diffuse large B-cell lymphoma across stages…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas [Phase 2]
Phase 2 trial evaluating nivolumab with or without varlilumab in relapsed or refractory aggressive B-cell lymphomas, including multiple DLBC…
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant [Phase 1, Phase 2]
This update reports results from a Phase 1/2 clinical trial of a gene therapy for HIV-related lymphomas in patients undergoing stem cell tra…
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of chemotherapy, rituximab, and ixazomib citrate in adults with various aggressive B-cell lymphomas…
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma [Phase 2]
Phase II trial update for dose-adjusted EPOCH-Rrituximab in adults with untreated Burkitt lymphoma and c-MYC positive diffuse large B-cell l…